Cala Health launches a device for the treatment of adults with Parkinson's by means of handtremor. The company announced the commercial launch of its nextgeneration Cala kIQ system, an FDA cleared wearable device for relief of hand tremors in people with essential tremor and Parkinson's disease.
Cala Health, Inc., a company developing wearable therapies for chronic diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cala Trio™ in October 2020 for the treatment of motor tremor in adults with Parkinson's disease.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5336
Published Date: Oct 19, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing prevalence of ET and growing innovation of new technologies are some of the major factors anticipated to drive the growth of the wearable tremor therapy market.
The market is anticipated to attain a CAGR of ~22% over the forecast period, i.e., 2024-2036.
The major players in the market are of Klick Health, Five Microns Inc., GYROGEAR Ltd., Indeigogo Inc., Microsoft Inc., Lift Labs, Neater Solutions, Steadiwear Inc., Readi-Steadi LLC., and others.
The gloves segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.